De novo MECP2 frameshift mutation in a boy with moderate mental retardation, obesity and gynaecomastia

被引:60
作者
Kleefstra, T
Yntema, HG
Oudakker, AR
Romein, T
Sistermans, E
Nillessen, W
van Bokhoven, H
de Vries, BBA
Hamel, BCJ
机构
[1] Radboud Univ Nijmegen Med Ctr, Dept Human Genet 417, NL-6500 HB Nijmegen, Netherlands
[2] Child Psychiat Observat Inst, Oisterwijk, Netherlands
关键词
D O I
10.1034/j.1399-0004.2002.610507.x
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Rett syndrome (RTT) is an X-linked neurodevelopmental disorder caused by mutations in the MECP2 gene, with apparent lethality in male embryos. However, recent studies indicate that mutations in the MECP2 gene can cause congenital encephalopathy, an Angelman-like phenotype and even nonspecific mental retardation in males. We report on a 10-year-old boy with moderate mental retardation, hypotonia, obesity and gynaecomastia and a de novo 2-bp deletion in the MECP2 gene that resulted in a frameshift and premature stop codon. As some of the clinical features were suggestive of the Prader-Willi syndrome, it might be worthwhile screening for MECP2 mutations in patients with an atypical Prader-Willi phenotype but without the characteristic abnormalities on chromosome 15q. This report contributes to the phenotypic knowledge of male patients with MECP2 mutations. Moreover, this is the first reported male case of a de novo MECP2 mutation.
引用
收藏
页码:359 / 362
页数:4
相关论文
共 15 条
[1]   MECP2 mutations account for most cases of typical forms of Rett syndrome [J].
Bienvenu, T ;
Carrié, A ;
de Roux, N ;
Vinet, MC ;
Jonveaux, P ;
Couvert, P ;
Villard, L ;
Arzimanoglou, A ;
Beldjord, C ;
Fontes, M ;
Tardieu, M ;
Chelly, J .
HUMAN MOLECULAR GENETICS, 2000, 9 (09) :1377-1384
[2]   Somatic mutation in MECP2 as a non-fatal neurodevelopmental disorder in males [J].
Clayton-Smith, J ;
Watson, P ;
Ramsden, S ;
Black, GCM .
LANCET, 2000, 356 (9232) :830-832
[3]   MECP2 is highly mutated in X-linked mental retardation [J].
Couvert, P ;
Bienvenu, T ;
Aquaviva, C ;
Poirier, K ;
Moraine, C ;
Gendrot, C ;
Verloes, A ;
Andrès, C ;
Le Fevre, AC ;
Souville, I ;
Steffann, J ;
des Portes, V ;
Ropers, HH ;
Yntema, HG ;
Fryns, JP ;
Briault, S ;
Chelly, J ;
Cherif, B .
HUMAN MOLECULAR GENETICS, 2001, 10 (09) :941-946
[4]   RETT SYNDROME - CRITERIA FOR INCLUSION AND EXCLUSION [J].
HAGBERG, B ;
GOUTIERES, F ;
HANEFELD, F ;
RETT, A ;
WILSON, J .
BRAIN & DEVELOPMENT, 1985, 7 (03) :372-373
[5]   MeCP2 mutations in children with and without the phenotype of Rett syndrome [J].
Hoffbuhr, K ;
Devaney, JM ;
LaFleur, B ;
Sirianni, N ;
Scacheri, C ;
Giron, J ;
Schuette, J ;
Innis, J ;
Marino, M ;
Philippart, M ;
Narayanan, V ;
Umansky, R ;
Kronn, D ;
Hoffman, EP ;
Naidu, S .
NEUROLOGY, 2001, 56 (11) :1486-1495
[6]   Rett syndrome:: analysis of MECP2 and clinical characterization of 31 patients [J].
Huppke, P ;
Laccone, F ;
Krämer, N ;
Engel, W ;
Hanefeld, F .
HUMAN MOLECULAR GENETICS, 2000, 9 (09) :1369-1375
[7]   MECP2 mutation in non-fatal, non-progressive encephalopathy in a male [J].
Imessaoudene, B ;
Bonnefont, JP ;
Royer, G ;
Cormier-Daire, V ;
Lyonnet, S ;
Lyon, G ;
Munnich, A ;
Amiel, J .
JOURNAL OF MEDICAL GENETICS, 2001, 38 (03) :171-174
[8]   A mutation in the Rett syndrome gene, MECP2, causes X-linked mental retardation and progressive spasticity in males [J].
Meloni, I ;
Bruttini, M ;
Longo, I ;
Mari, F ;
Rizzolio, F ;
D'Adamo, P ;
Denvriendt, K ;
Fryns, JP ;
Toniolo, D ;
Renieri, A .
AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (04) :982-985
[9]   A SIMPLE SALTING OUT PROCEDURE FOR EXTRACTING DNA FROM HUMAN NUCLEATED CELLS [J].
MILLER, SA ;
DYKES, DD ;
POLESKY, HF .
NUCLEIC ACIDS RESEARCH, 1988, 16 (03) :1215-1215
[10]   MECP2 mutation in male patients with non-specific X-linked mental retardation [J].
Orrico, A ;
Lam, CW ;
Galli, L ;
Dotti, MT ;
Hayek, G ;
Tong, SF ;
Poon, PMK ;
Zappella, M ;
Federico, A ;
Sorrentino, V .
FEBS LETTERS, 2000, 481 (03) :285-288